Gene Therapy for Rare Disorders USA 2022

We hope you enjoyed the Gene Therapy for Rare Disorders USA 2022 event where our subject matter expert presented on standardizing process characterization for AAV-based vaccine manufacturing.

Highlights included:

  • Top tips on how to establish an effective standardized Process Characterization program
  • Utilizing qualified Scale Down Models (SDMs), an imperative part of biologics licensure applications
  • Defining a Process Control Strategy for the product’s journey from early access to clinics to commercial manufacturing

Anjali Singh
Lead Scientist- Process Sciences, Thermo Fisher Scientific

Anjali Singh

Should we have missed out on connecting at Gene Therapy for Rare Disorders USA 2022, reach out to us to find out more about how we help pharma and new and emerging biotech companies turn pharmaceutical possibilities into realities and get to market faster.

Request a meeting

Please fill out the form below or press submit if you're a return visitor to our site.